GlassScriptPhysician profile
Lisa Angel
NPI 1073282992
$1,483.68
in general payments reported to CMS, 2019-2025
28 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.35 · 2022: $307 · 2023: $65.46 · 2024: $648 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Education: $62.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.29 |
| Education | $62.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $234.41 | 2022 | |
| Novo Nordisk INC | $157.34 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $120.82 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $117.62 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $98.19 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.19 | 2024 | Synjardy, Tradjenta, Jardiance |
| Amgen INC. | $70.49 | 2024-2025 | Evenity, Prolia, Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $60.34 | 2024 | |
| Insulet Corporation | $56.14 | 2025 | Omnipod |
| Beta Bionics, INC. | $44.37 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Sequel Med Tech, LLC | $40.74 | 2025 | Twiist |
| Recordati_rare_diseases_inc. | $37.68 | 2023-2024 | Isturisa |
| Ascensia Diabetes Care US INC. | $31.38 | 2024-2025 | |
| Antares Pharma, INC. | $31.35 | 2024 | Xyosted |
| Nevro Corp. | $28.98 | 2024 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ionis Pharmaceuticals, INC. | $26.48 | 2025 | Tryngolza |
| Verity Pharmaceuticals INC. | $23.85 | 2025 | Tlando |
| Xeris Pharmaceuticals, INC. | $23.82 | 2024 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $23.39 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $21.81 | 2024 | Minimed 780g |
| Cequr Corporation | $21.43 | 2025 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $20.70 | 2025 | Rezdiffra |
| Chiesi USA, INC. | $20.10 | 2024 | Mycapssa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.60 | 2022 | |
| Corcept Therapeutics | $17.96 | 2024 | Korlym |
| Galderma Laboratories, L.P. | $17.19 | 2023 | |
| Amneal Pharmaceuticals LLC | $17.09 | 2024 | Unithroid |
| Currax Pharmaceuticals LLC | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.